SME Times is powered by   
Search News
Just in:   • Delayed Payments - Barrier To MSME Growth  • PM Modi arrives in Karnataka, to reach Udupi in Army special chopper  • US-proposed list of points on Ukraine could form basis for future agreements: Putin  • Gold, silver prices rise on strong demand  • Iran's Supreme Leader says no message sent to US through third countries 
Last updated: 13 Oct, 2021  

Indonesia.9.Thmb.jpg Indonesia reports 1,233 new Covid cases, 48 more deaths

Indonesia.9.jpg
   Top Stories
» Gold, silver prices rise on strong demand
» Reliance Industries gets Rs 56.44 crore CGST penalty
» Sensex, Nifty turn positive after early losses ahead of key Q2 GDP data release
» RBI’s all-India House Price Index rises by 2.2 pc in Q2 of 2025-26
» India, Slovenia express optimism for early conclusion of EU FTA
IANS | 13 Oct, 2021
The number of Covid-19 cases in Indonesia rose by 1,233 within one day to 4,231,046, with the death toll adding by 48 to 142,811, the country's Health Ministry said on Wednesday.

According to the ministry, 2,259 more people were discharged from hospitals, bringing the total number of patients recovering from Covid-19 to 4,067,684, the Xinhua news agency reported.

To date, at least 59.41 million people in the country have received two shots of vaccines, while 102.68 million have taken their first doses, the ministry added.

The Indonesian government is targeting to vaccinate 208.2 million people in the country.
 
Print the Page
Add to Favorite
 
Share this on :
 

Please comment on this story:
 
Subject :
Message:
(Maximum 1500 characters)  Characters left 1500
Your name:
 

 
  Customs Exchange Rates
Currency Import Export
US Dollar
₹88.70
₹87
UK Pound
₹119.90
₹116
Euro
₹104.25
₹100.65
Japanese Yen ₹59.20 ₹57.30
As on 30 Oct, 2025
  Daily Poll
Who do you think will benefit more from the India - UK FTA in the long run?
 Indian businesses & consumers.
 UK businesses & consumers.
 Both will gain equally.
 The impact will be negligible for both.
  Commented Stories
 
 
About Us  |   Advertise with Us  
  Useful Links  |   Terms and Conditions  |   Disclaimer  |   Contact Us  
Follow Us : Facebook Twitter